STEPHANIE TILLEY: Open Payments
NPI 1316709009 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,992 in 132 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,703 · 2025 $2,992
Food & beverage: $2,898Education: $94
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 28 | $755 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $475 |
| ABBVIE INC. | 17 | $285 |
| PFIZER INC. | 11 | $236 |
| Madrigal Pharmaceuticals | 8 | $181 |
| Lilly USA, LLC | 8 | $176 |
| GENZYME CORPORATION | 6 | $158 |
| Celltrion USA Inc. | 10 | $144 |
| Ipsen Biopharmaceuticals, Inc | 4 | $115 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $100 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, OMVOH, DUPIXENT, VEGZELMA, SKYRIZI, VELSIPITY.
Industry payments across AZ — which companies pay providers there.
